1832 Asset Management L.P. Adma Biologics, Inc. Transaction History
1832 Asset Management L.P.
- $55.8 Billion
- Q3 2024
A detailed history of 1832 Asset Management L.P. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, 1832 Asset Management L.P. holds 437,900 shares of ADMA stock, worth $7.02 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
437,900
Previous 587,900
25.51%
Holding current value
$7.02 Million
Previous $6.57 Million
33.19%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
317Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$299 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$290 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$208 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$202 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$138 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.15B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...